Head and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrences

BACKGROUND: We investigated the prognostic role of tumour-associated macrophages (TAMs) in patients with head and neck squamous cell carcinoma (HNSCC) treated with definitive chemoradiotherapy (CRT). METHODS: The expression of CD68+, CD163+ and CD11b+ cells was assessed using immunohistochemistry in...

Descripción completa

Detalles Bibliográficos
Autores principales: Balermpas, P, Rödel, F, Liberz, R, Oppermann, J, Wagenblast, J, Ghanaati, S, Harter, P N, Mittelbronn, M, Weiss, C, Rödel, C, Fokas, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200089/
https://www.ncbi.nlm.nih.gov/pubmed/25093488
http://dx.doi.org/10.1038/bjc.2014.446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200089/
https://www.ncbi.nlm.nih.gov/pubmed/25093488
http://dx.doi.org/10.1038/bjc.2014.446

Ejemplares similares